Antibiotic resistance of bacterial ventilator-associated pneumonia in surgical intensive care units

Related Experiment Video

Updated: Aug 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

M Namiduru1, G Güngör, I Karaoğlan

  • 1Department of Infectious Diseases, Medical Faculty, Gaziantep University, Gaziantep, Turkey.

The Journal of International Medical Research
|March 5, 2004
PubMed

Insights

Ventilator-associated pneumonia (VAP) is a common ICU infection. This study identified key bacteria and antibiotic resistance, suggesting targeted therapies and hospital antibiotic policies to combat VAP.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU) infection.
  • VAP is associated with prolonged hospitalization and high mortality rates.
  • Understanding causative pathogens and antibiotic resistance is crucial for effective VAP management.

Purpose of the Study:

  • To identify the primary bacterial agents responsible for VAP in a surgical ICU.
  • To determine the antibiotic resistance patterns of these VAP-causing bacteria.
  • To inform optimal antibiotic treatment strategies for VAP.

Main Methods:

  • Retrospective clinical study of 140 patients in a surgical ICU.
  • Bacterial identification through culturing tracheal aspirates from patients with VAP.
  • Antibiotic sensitivity testing performed on isolated bacterial strains.

Main Results:

  • The most frequent isolates were Pseudomonas aeruginosa (33.9%), Staphylococcus aureus (30.0%), and Acinetobacter baumannii (26.1%).
  • Acinetobacter baumannii showed increased prevalence compared to previous years.
  • Sulbactam/cefoperazone demonstrated effectiveness, with specific recommendations for staphylococcal pneumonia.

Conclusions:

  • Hospital-specific antibiotic policies are essential for reducing VAP-related antibiotic resistance.
  • Targeted antibiotic selection based on local resistance patterns can improve VAP treatment outcomes.
  • Prompt identification of pathogens and resistance is key to managing VAP effectively.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...